Tryptophan Metabolism Disorder-Triggered Diseases, Mechanisms, and Therapeutic Strategies: A Scientometric Review

被引:1
|
作者
Chen, Xue [1 ,2 ]
Xu, Dong [1 ,2 ]
Yu, Jie [1 ,2 ]
Song, Xu-Jiao [1 ,2 ]
Li, Xue [1 ,2 ]
Cui, Yuan-Lu [1 ,2 ]
机构
[1] Tianjin Univ Tradit Chinese Med, Haihe Lab Modern Chinese Med, Tianjin 301617, Peoples R China
[2] Tianjin Univ Tradit Chinese Med, Res Ctr Tradit Chinese Med, State Key Lab Component Based Chinese Med, Tianjin 301617, Peoples R China
关键词
tryptophan metabolism; scientometric analysis; gut microbiota; COVID-19; depression; ARYL-HYDROCARBON RECEPTOR; DEPRESSIVE-LIKE BEHAVIOR; INDOLEAMINE 2,3-DIOXYGENASE; GUT MICROBIOTA; KYNURENINE PATHWAY; IMMUNE CHECKPOINT; UP-REGULATION; MOUSE MODEL; ACID; INHIBITOR;
D O I
10.3390/nu16193380
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Tryptophan is widely present in foods such as peanuts, milk, and bananas, playing a crucial role in maintaining metabolic homeostasis in health and disease. Tryptophan metabolism is involved in the development and progression of immune, nervous, and digestive system diseases. Although some excellent reviews on tryptophan metabolism exist, there has been no systematic scientometric study as of yet. Methods: This review provides and summarizes research hotspots and potential future directions by analyzing annual publications, topics, keywords, and highly cited papers sourced from Web of Science spanning 1964 to 2022. Results: This review provides a scientometric overview of tryptophan metabolism disorder-triggered diseases, mechanisms, and therapeutic strategies. Conclusions: The gut microbiota regulates gut permeability, inflammation, and host immunity by directly converting tryptophan to indole and its derivatives. Gut microbial metabolites regulate tryptophan metabolism by activating specific receptors or enzymes. Additionally, the kynurenine (KYN) pathway, activated by indoleamine-2, 3-dioxygenase (IDO) and tryptophan 2, 3-dioxygenase, affects the migration and invasion of glioma cells and the development of COVID-19 and depression. The research and development of IDO inhibitors help to improve the effectiveness of immunotherapy. Tryptophan metabolites as potential markers are used for disease therapy, guiding clinical decision-making. Tryptophan metabolites serve as targets to provide a new promising strategy for neuroprotective/neurotoxic imbalance affecting brain structure and function. In summary, this review provides valuable guidance for the basic research and clinical application of tryptophan metabolism.
引用
收藏
页数:26
相关论文
共 25 条
  • [1] Tryptophan Metabolism in Central Nervous System Diseases: Pathophysiology and Potential Therapeutic Strategies
    Huang, Yinrou
    Zhao, Mengke
    Chen, Xuemei
    Zhang, Ruoyu
    Le, Anh
    Hong, Michael
    Zhang, Yufei
    Jia, Lin
    Zang, Weidong
    Jiang, Chao
    Wang, Junmin
    Fan, Xiaochong
    Wang, Jian
    AGING AND DISEASE, 2023, 14 (03): : 858 - 878
  • [2] Molecular mechanisms and therapeutic significance of Tryptophan Metabolism and signaling in cancer
    Yan, Jing
    Chen, Di
    Ye, Zi
    Zhu, Xuqiang
    Li, Xueyuan
    Jiao, Henan
    Duan, Mengjiao
    Zhang, Chaoli
    Cheng, Jingliang
    Xu, Lixia
    Li, Hongjiang
    Yan, Dongming
    MOLECULAR CANCER, 2024, 23 (01)
  • [3] Exploring tryptophan metabolism: The transition from disturbed balance to diagnostic and therapeutic potential in metabolic diseases
    Luo, Zhizhong
    Liu, Yuqing
    Wang, Xin
    Fan, Faxin
    Yang, Zhenzhen
    Luo, Duosheng
    BIOCHEMICAL PHARMACOLOGY, 2024, 230
  • [4] Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases
    Michaudel, Chloe
    Danne, Camille
    Agus, Allison
    Magniez, Aurelie
    Aucouturier, Anne
    Spatz, Madeleine
    Lefevre, Antoine
    Kirchgesner, Julien
    Rolhion, Nathalie
    Wang, Yazhou
    Lavelle, Aonghus
    Galbert, Chloe
    Da Costa, Gregory
    Poirier, Maxime
    Lapiere, Alexia
    Planchais, Julien
    Nadvornik, Petr
    Illes, Peter
    Oeuvray, Cyriane
    Creusot, Laura
    Michel, Marie-Laure
    Benech, Nicolas
    Bourrier, Anne
    Nion-Larmurier, Isabelle
    Landman, Cecilia
    Richard, Mathias L.
    Emond, Patrick
    Seksik, Philippe
    Beaugerie, Laurent
    Arguello, Rafael Rose
    Moulin, David
    Mani, Sridhar
    Dvorak, Zdenek
    Bermudez-Humaran, Luis G.
    Langella, Philippe
    Sokol, Harry
    GUT, 2023, 72 (07) : 1296 - 1307
  • [5] Understanding the physiological mechanisms and therapeutic targets of diseases: Lipidomics strategies
    Yang, Qiang
    Cai, Ying
    Wang, Zhibo
    Guo, Sifan
    Qiu, Shi
    Zhang, Aihua
    LIFE SCIENCES, 2025, 363
  • [6] The therapeutic potential of diet on immune-related diseases: based on the regulation on tryptophan metabolism
    Lin, Junjie
    Sun-Waterhouse, Dongxiao
    Cui, Chun
    CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2022, 62 (31) : 8793 - 8811
  • [7] Does Exercise Influence Kynurenine/Tryptophan Metabolism and Psychological Outcomes in Persons With Age-Related Diseases? A Systematic Review
    Lim, Anthony
    Harijanto, Christel
    Vogrin, Sara
    Guillemin, Gilles
    Duque, Gustavo
    INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH, 2021, 14
  • [8] Adaptation mechanisms in cancer: Lipid metabolism under hypoxia and nutrient deprivation as a target for novel therapeutic strategies (Review)
    Koizume, Shiro
    Miyagi, Yohei
    MOLECULAR MEDICINE REPORTS, 2025, 31 (04)
  • [9] Underlying Mechanisms of Brain Aging and Neurodegenerative Diseases as Potential Targets for Preventive or Therapeutic Strategies Using Phytochemicals
    Abdolmaleky, Hamid Mostafavi
    Zhou, Jin-Rong
    NUTRIENTS, 2023, 15 (15)
  • [10] Impact of Substance Use Disorder on Tryptophan Metabolism Through the Kynurenine Pathway: A Narrative Review
    Contella, Lindsey
    Farrell, Christopher L.
    Boccuto, Luigi
    Litwin, Alain H.
    Snyder, Marion L.
    METABOLITES, 2024, 14 (11)